AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 86 filers reported holding AVROBIO INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $25,000 | -67.9% | 18,810 | -6.6% | 0.00% | – |
| Q4 2021 | $78,000 | -32.8% | 20,134 | -2.9% | 0.00% | -100.0% |
| Q3 2021 | $116,000 | -35.9% | 20,737 | +2.0% | 0.00% | 0.0% |
| Q2 2021 | $181,000 | -31.2% | 20,326 | -1.9% | 0.00% | 0.0% |
| Q1 2021 | $263,000 | +4.0% | 20,710 | +14.0% | 0.00% | 0.0% |
| Q4 2020 | $253,000 | +4.1% | 18,160 | -2.8% | 0.00% | 0.0% |
| Q3 2020 | $243,000 | -26.4% | 18,682 | -1.1% | 0.00% | -50.0% |
| Q2 2020 | $330,000 | +52.8% | 18,892 | +36.1% | 0.00% | +100.0% |
| Q1 2020 | $216,000 | -16.9% | 13,877 | +7.5% | 0.00% | 0.0% |
| Q4 2019 | $260,000 | +41.3% | 12,904 | -0.8% | 0.00% | 0.0% |
| Q3 2019 | $184,000 | +13.6% | 13,013 | +30.5% | 0.00% | 0.0% |
| Q2 2019 | $162,000 | -9.5% | 9,972 | +22.9% | 0.00% | 0.0% |
| Q1 2019 | $179,000 | +167.2% | 8,111 | +102.2% | 0.00% | – |
| Q4 2018 | $67,000 | -68.1% | 4,011 | -0.7% | 0.00% | -100.0% |
| Q3 2018 | $210,000 | – | 4,041 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,236,123 | $21,570,000 | 14.96% |
| Aisling Capital Management LP | 1,009,779 | $17,621,000 | 6.72% |
| Burrage Capital Management LLC | 225,900 | $3,942,000 | 2.76% |
| New Leaf Venture Partners, L.L.C. | 315,550 | $5,506,000 | 1.58% |
| TANG CAPITAL MANAGEMENT LLC | 800,000 | $13,960,000 | 1.36% |
| Camber Capital Management LP | 1,350,000 | $23,558,000 | 1.35% |
| Parkman Healthcare Partners LLC | 190,593 | $3,326,000 | 0.94% |
| Eventide Asset Management | 1,905,307 | $33,248,000 | 0.72% |
| Penn Mutual Asset Management | 37,306 | $651,000 | 0.66% |
| EMERALD ADVISERS, LLC | 832,474 | $14,527,000 | 0.63% |